Mesothelioma: VS-5584 Received Orphan Drug Designation

Verastem. Inc, a pharmaceutical company focused on the discovery and development of drugs directed against cancer stem cells, recently announced that VS-5584, oral inhibitor of focal adhesion kinase (FAK), has received orphan drug designation from the US Food and Drug Administration, for use in the treatment of mesothelioma.

It is an important regulatory milestone for Verastem that will facilitate the global development of the VS-5584, and that will help improve the treatment options available for patients suffering from this type of very aggressive cancer, said Robert Forrester, President Verastem.

Verastem has recently initiated a Phase 1 clinical study in order to evaluate the synergistic activity in combination with VS-5584 VS-6063, in patients with progressive or relapsed malignant pleural mesothelioma.

Moreover VS-5584 is subjected to a phase 1 further study to evaluate the use against advanced solid tumors, such as mesothelioma, in patients who have previously shown good tolerance to the drug.

Comments

General Information about Malignant Mesothelioma

Malignant mesothelioma is a disease in which malignant (cancerous) cells form in the lining of the chest or abdomen. Malignant mesothelioma is a disease in which malignant (cancer) cells are found in the pleura (the thin layer of tissue that lines the chest cavity and covers the lungs) or the peritoneum (the thin layer of tissue that lines the abdomen and covers most of the organs of the abdomen). Malignant mesothelioma can form in the heart or testicles, but this is not common Exposure to asbestos can influence the risk of malignant mesothelioma. Anything that increases the risk of getting a disease is called a risk factor. Having a risk factor does not mean you are going to have cancer; Having no risk factors does not mean you will not have cancer. Talk to your doctor if you think you may be at risk. Most people with malignant mesothelioma have worked or lived in places where they inhaled or swallowed asbestos. After exposure to asbestos, it usually takes a lon...

Legal Options After A diagnosis of Mesothelioma

If your doctor diagnosed you or a loved one with mesothelioma, it is important to follow their recommendations to the letter. It is also advisable to receive legal advice from an experienced lawyer, since you could receive compensation for medical expenses, treatments, pain, suffering and lost wages. If you decide to seek legal help, there are three very important questions that a lawyer will ask you: Were you or your loved one exposed to asbestos or asbestos? Where and when did this exposure to asbestos occur? What damage did the person suffer as a result of exposure to asbestos? Exposure to asbestos at work If the asbestos exposure occurred at work, you could file a lawsuit against your employer. If you worked in the following industries, it is very likely that you were exposed to asbestos: Building Factories / manufacturing Firefighters Naval building ...

Mesothelioma, Treatments Are More Effective Thanks To Grape Seeds

In Italy it represents 0.4% of all malignancies diagnosed in men and 0.2% of those diagnosed in women. The study was born from the collaboration between ENEA, CNR and the "Federico II" University of Naples Mesothelioma is a tumor that arises from the cells that line the mesothelium. It is a fabric that covers the surface of the serous membranes which, in turn, line the inner wall of the chest, abdomen and space around the heart. Depending on the affected area, the mesothelium takes on different names. The main risk factor for this disease is exposure to asbestos. This term indicates a family of minerals rather common in nature with a fibrous structure very resistant to heat. Its fibers, if inhaled, settle in the lungs and can damage the mesothelial cells causing, in some cases, pleural cancer. Other less common risk factors are exposure to zeolites with erionitis, radiation to the chest and abdomen, thorium injections (used in medicine until 1950). According ...

Mesothelioma Pathology Outlines

Search This Blog